A phase III comparative trial of benzathine penicillin g, 2.4 million units administered as a single dose versus three successive weekly doses for treatment of early syphilis in persons with and…
Ended Awarded Last action
- Contract number
- HHSN27200014
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,196,307
Award facts
- Contract value 100% obligated
- $3,196,306.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$15,655 | |
| Supplemental Agreement for work within scope | -$51,202 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,339,905 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,384,298 | |
| Original award | $538,961 |
Show all 11
About this award
This is a $3,196,306.96 delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham. The contract is for a Phase III comparative clinical trial to evaluate two treatment regimens of benzathine penicillin G for early syphilis in individuals with and without HIV. The study will be conducted at multiple sites, with subcontractors including Louisiana State University Health Sciences Center New Orleans, Wake Forest University, and Fenway Community Health Center, Inc. This delivery order contract is part of a larger unknown federal contract vehicle. No set-aside designation was used for this award.
Description
A phase III comparative trial of benzathine penicillin g, 2.4 million units administered as a single dose versus three successive weekly doses for treatment of early syphilis in persons with and without HIV.
Quick answers
Who was awarded contract HHSN27200014?
HHSN27200014 was awarded to University Of Alabama At Birmingham by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 31, 2017.
How much is contract HHSN27200014 worth?
The government has obligated $3,196,307 on HHSN27200014.
Is contract HHSN27200014 an order under another contract?
Yes. HHSN27200014 is a delivery order under HHSN272201300012I, an indefinite delivery contract.
Was contract HHSN27200014 competed?
The extent of competition for HHSN27200014 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award